Unresolved disorder model. using A ATOM 320 N ASER 61 -33.833 -0.490 -0.946 0.28 24.06 N Unresolved disorder model. using A ATOM 321 N BSER 61 -33.832 -0.492 -0.946 0.73 23.50 N Unresolved disorder model. using A ATOM 322 CA ASER 61 -33.898 -0.732 -2.384 0.28 26.66 C Unresolved disorder model. using A ATOM 323 CA BSER 61 -33.850 -0.744 -2.384 0.73 26.85 C Unresolved disorder model. using A ATOM 324 C ASER 61 -33.045 0.289 -3.131 0.28 25.63 C Unresolved disorder model. using A ATOM 325 C BSER 61 -32.938 0.244 -3.099 0.73 25.06 C Unresolved disorder model. using A ATOM 326 O ASER 61 -32.691 1.333 -2.578 0.28 24.51 O Unresolved disorder model. using A ATOM 327 O BSER 61 -32.455 1.205 -2.497 0.73 24.11 O Unresolved disorder model. using A ATOM 328 CB ASER 61 -35.342 -0.681 -2.876 0.28 29.61 C Unresolved disorder model. using A ATOM 329 CB BSER 61 -35.274 -0.639 -2.929 0.73 30.76 C Unresolved disorder model. using A ATOM 330 OG ASER 61 -35.811 -1.962 -3.267 0.28 33.73 O Unresolved disorder model. using A ATOM 331 OG BSER 61 -35.742 0.697 -2.838 0.73 31.42 O Unresolved disorder model. using A ATOM 647 N AMET 104 -27.278 -9.560 5.889 0.41 19.37 N Unresolved disorder model. using A ATOM 648 N BMET 104 -27.259 -9.578 5.898 0.59 19.27 N Unresolved disorder model. using A ATOM 649 CA AMET 104 -28.003 -9.568 4.628 0.41 19.06 C Unresolved disorder model. using A ATOM 650 CA BMET 104 -27.927 -9.483 4.616 0.59 19.25 C Unresolved disorder model. using A ATOM 651 C AMET 104 -27.042 -9.811 3.466 0.41 20.65 C Unresolved disorder model. using A ATOM 652 C BMET 104 -26.992 -9.850 3.471 0.59 20.74 C Unresolved disorder model. using A ATOM 653 O AMET 104 -25.880 -9.403 3.495 0.41 21.66 O Unresolved disorder model. using A ATOM 654 O BMET 104 -25.792 -9.566 3.500 0.59 18.79 O Unresolved disorder model. using A ATOM 655 CB AMET 104 -28.774 -8.258 4.437 0.41 17.12 C Unresolved disorder model. using A ATOM 656 CB BMET 104 -28.456 -8.053 4.446 0.59 16.73 C Unresolved disorder model. using A ATOM 657 CG AMET 104 -27.922 -7.036 4.161 0.41 14.84 C Unresolved disorder model. using A ATOM 658 CG BMET 104 -28.920 -7.693 3.047 0.59 14.49 C Unresolved disorder model. using A ATOM 659 SD AMET 104 -28.860 -5.644 3.503 0.41 17.06 S Unresolved disorder model. using A ATOM 660 SD BMET 104 -29.631 -6.037 2.961 0.59 17.63 S Unresolved disorder model. using A ATOM 661 CE AMET 104 -29.396 -6.298 1.927 0.41 21.47 C Unresolved disorder model. using A ATOM 662 CE BMET 104 -28.162 -5.030 2.928 0.59 18.13 C Unresolved disorder model. using A ATOM 1422 CA ASER 217 -23.492 2.798 22.370 0.83 16.69 C Unresolved disorder model. using A ATOM 1423 CA BSER 217 -23.500 2.801 22.353 0.17 17.47 C Unresolved disorder model. using A ATOM 1426 CB ASER 217 -23.849 2.661 23.843 0.83 19.86 C Unresolved disorder model. using A ATOM 1427 CB BSER 217 -23.869 2.685 23.823 0.17 18.35 C Unresolved disorder model. using A ATOM 1428 OG ASER 217 -23.326 1.504 24.453 0.83 33.32 O Unresolved disorder model. using A ATOM 1429 OG BSER 217 -23.795 3.946 24.473 0.17 0.01 O Unresolved disorder model. using A ATOM 1472 CA ALYS 224 -18.929 0.543 25.470 0.48 23.83 C Unresolved disorder model. using A ATOM 1473 CA BLYS 224 -18.946 0.463 25.490 0.52 23.86 C Unresolved disorder model. using A ATOM 1476 CB ALYS 224 -19.581 1.910 25.268 0.48 24.38 C Unresolved disorder model. using A ATOM 1477 CB BLYS 224 -19.776 1.739 25.371 0.52 24.58 C Unresolved disorder model. using A ATOM 1478 CG ALYS 224 -20.123 2.549 26.537 0.48 26.06 C Unresolved disorder model. using A ATOM 1479 CG BLYS 224 -20.807 1.905 26.479 0.52 26.44 C Unresolved disorder model. using A ATOM 1480 CD ALYS 224 -21.350 3.400 26.257 0.48 27.43 C Unresolved disorder model. using A ATOM 1481 CD BLYS 224 -21.873 0.821 26.452 0.52 33.57 C Unresolved disorder model. using A ATOM 1482 CE ALYS 224 -21.167 4.850 26.681 0.48 32.22 C Unresolved disorder model. using A ATOM 1483 CE BLYS 224 -22.941 1.047 27.512 0.52 34.66 C Unresolved disorder model. using A ATOM 1484 NZ ALYS 224 -22.339 5.695 26.312 0.48 36.10 N Unresolved disorder model. using A ATOM 1485 NZ BLYS 224 -22.340 1.056 28.879 0.52 26.75 N Unresolved disorder model. using A ATOM 1626 CA AILE 242 -26.249 -18.013 -2.691 0.35 17.73 C Unresolved disorder model. using A ATOM 1627 CA BILE 242 -26.380 -17.944 -2.744 0.65 18.10 C Unresolved disorder model. using A ATOM 1630 CB AILE 242 -24.732 -17.821 -2.507 0.35 18.48 C Unresolved disorder model. using A ATOM 1631 CB BILE 242 -24.966 -17.360 -2.606 0.65 19.00 C Unresolved disorder model. using A ATOM 1632 CG1AILE 242 -24.335 -16.527 -1.798 0.35 18.90 C Unresolved disorder model. using A ATOM 1633 CG1BILE 242 -23.841 -18.377 -2.773 0.65 19.80 C Unresolved disorder model. using A ATOM 1634 CG2AILE 242 -24.025 -17.930 -3.851 0.35 23.84 C Unresolved disorder model. using A ATOM 1635 CG2BILE 242 -24.844 -16.620 -1.282 0.65 23.56 C Unresolved disorder model. using A ATOM 1636 CD1AILE 242 -22.886 -16.564 -1.347 0.35 20.84 C Unresolved disorder model. using A ATOM 1637 CD1BILE 242 -23.421 -19.047 -1.493 0.65 40.96 C 1